Twist Bioscience Corp Stock Investor Sentiment
| TWST Stock | USD 30.75 0.75 2.38% |
Slightly above 67% of Twist Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Twist Bioscience Corp suggests that many traders are alarmed. Twist Bioscience's investor sentiment overview provides quick insight into current market opportunities from investing in Twist Bioscience Corp. The current market sentiment, together with Twist Bioscience's historical and current headlines, can help investors time the market. In addition, many technical investors use Twist Bioscience Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
33
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Twist Bioscience's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Twist Bioscience Corp.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Twist Bioscience stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Twist daily returns and investor perception about the current price of Twist Bioscience Corp as well as its diversification or hedging effects on your existing portfolios.
Twist Historical Sentiment
Although Twist Bioscience's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Twist, such as negative comments on social media and news outlets, may cause fear in the market and push Twist Bioscience's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Twist.
Twist |
Twist Bioscience Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Twist Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Twist Bioscience Corp Historical Investor Sentiment
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience news discussions. The higher the estimate score, the more favorable the investor's outlook on Twist Bioscience.
Twist Bioscience Maximum Pain Price across 2024-05-17 Option Contracts
Twist Bioscience's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Twist Bioscience close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Twist Bioscience's options.
Far too much social signal, news, headlines, and media speculation about Twist Bioscience that are available to investors today. That information is available publicly through Twist media outlets and privately through word of mouth or via Twist internal channels. However, regardless of the origin, that massive amount of Twist data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Twist Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Twist Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Twist Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Twist Bioscience alpha.
Twist Bioscience Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results | 02/02/2024 |
2 | Is The Stock Market Ready To Plunge The Warning Signs Are Here... | 02/21/2024 |
3 | Disposition of 549 shares by William Banyai of Twist Bioscience at 37.43 subject to Rule 16b-3 | 03/06/2024 |
4 | Disposition of tradable shares by Dennis Cho of Twist Bioscience at 34.6 subject to Rule 16b-3 | 03/14/2024 |
5 | Can Twist Bioscience Corp Stock Rise to the Top of Healthcare Sector Friday - InvestorsObserver | 03/15/2024 |
6 | Twist Bioscience exec sells shares to cover tax obligations | 03/18/2024 |
7 | Twist Bioscience Co. Shares Sold by Nordea Investment Management AB - Defense World | 03/21/2024 |
8 | Twist Bioscience executive sells shares worth over 7,700 | 03/22/2024 |
9 | Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations | 03/28/2024 |
10 | Disposition of 229 shares by Paula Green of Twist Bioscience at 32.736 subject to Rule 16b-3 | 04/02/2024 |
11 | Recent 3.3 percent pullback isnt enough to hurt long-term Twist Bioscience shareholders, theyre still up 149 percent over 1 year | 04/04/2024 |
12 | Disposition of 556 shares by Adam Laponis of Twist Bioscience at 33.155 subject to Rule 16b-3 | 04/09/2024 |
13 | Twist Bioscience Shares Gap Down to 33.73 - MarketBeat | 04/10/2024 |
14 | Mirae Asset Global Investments Co. Ltd. Has 4.41 Million Position in Twist Bioscience Co. - Defense World | 04/16/2024 |
Check out Twist Bioscience Hype Analysis, Twist Bioscience Correlation and Twist Bioscience Performance. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.61) | Revenue Per Share 4.591 | Quarterly Revenue Growth 0.318 | Return On Assets (0.16) | Return On Equity (0.31) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.